satraplatin News
Most Popular satraplatin Story
GPC shares crater on Phase III cancer failure
Germany's GPC Biotech saw its already battered stock price crater this morning after announcing that its experimental prostate cancer drug, satraplatin, failed to help patients live longer in a... Read more...
Latest Headlines
- August 6, 2008
- May 7, 2008
- November 28, 2007
- November 15, 2007
- November 9, 2007
- October 31, 2007
- August 23, 2007
- August 8, 2007
- August 1, 2007
- July 30, 2007
- July 25, 2007
- July 23, 2007
- November 15, 2006
- September 24, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
